Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05657821
Other study ID # Indonesia TimurU
Secondary ID
Status Recruiting
Phase Early Phase 1
First received
Last updated
Start date October 25, 2022
Est. completion date August 25, 2023

Study information

Verified date December 2022
Source Indonesia Timur University
Contact Rosdiana Syakur
Phone +6285299856839
Email rosdianaary@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this to measure the effect of supplementation of Yellow Pumpkin Seed Extract Capsules in pregnant women on hemoglobin levels and nutritional status of pregnant women. The main question[s] it aims to answer are: - is there a difference in changes in nutritional status (increase in body weight and MUAC) in pregnant women who receive supplementation of Pumpkin Seed Extract Capsules and iron tablets - is there a difference in changes in hemoglobin levels in pregnant women who receive supplementation of Pumpkin Seed Extract Capsules and iron tablets. The research sample was divided into two groups, namely the intervention group and the control group. In the intervention group, pregnant women received pumpkin seed extract capsules for 12 weeks, while the control group received iron tablets for 12 weeks as well. Measurements of nutritional status (including measurements of body weight and Mid Upper Arm Circumference/MUAC) were carried out before and after the intervention and were monitored every month until 12 weeks when the intervention was carried out. As for measuring blood hemoglobin levels, it was taken before the intervention and after the intervention for 12 weeks


Description:

This study was designed with an experimental method using a randomized double blind with a control group. The research sample was divided into two groups, namely the intervention group and the control group. In the intervention group, pregnant women received pumpkin seed extract capsules for 12 weeks, while the control group received iron tablets for 12 weeks as well. Measurements of nutritional status (including measurements of body weight and Mid Upper Arm Circumference/MUAC) were carried out before and after the intervention and were monitored every month until 12 weeks when the intervention was carried out. As for measuring blood hemoglobin levels, it was taken before the intervention and after the intervention for 12 weeks. The research will be conducted in the village of the stunting locus, Bone Regency, South Sulawesi, Indonesia. Data analysis was carried out with SPSS, where to see the difference between the intervention group and the contro group, a paired t test was used if the data was normally distributed and an alternative test if the data was not normally distributed.


Recruitment information / eligibility

Status Recruiting
Enrollment 70
Est. completion date August 25, 2023
Est. primary completion date January 25, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 17 Years to 39 Years
Eligibility Inclusion Criteria: 1. in the one or second trimester of pregnancy; 2. having no complications; 3. willing to participate in this study; 4. domiciled in the stunting locus village Bone regency . Exclusion Criteria: - Pregnant women with complications

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Pumpkin seeds extract capsules
the intervention group was given pumpkin seed capsules for 12 weeks, and the intervention group was given iron tablets for 12 weeks

Locations

Country Name City State
Indonesia Stunting Locus Village Bone South Sulawesi

Sponsors (2)

Lead Sponsor Collaborator
Dr. Rosdiana Syakur Hasanuddin University

Country where clinical trial is conducted

Indonesia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Nutritional status measurements of body weight and Mid Upper Arm Circumference/MUAC) were carried out before and after the intervention and were monitored every month until 12 weeks when the intervention was carried out 12 weeks
Primary hemoglobin levels Hemoglobin level in the blood is measured by taking blood from the fingertip. Then measured using the digital strip method. 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT03202615 - Bovine Lactoferrin Versus Ferrous Sulphate In The Treatment Of Iron Deficiency Anemia During Pregnancy Phase 4
Completed NCT02191527 - Evaluating the Effectiveness of Point-of-care Diagnostic Technologies in MCH Services in Mozambique N/A